tiragolumab (RG6058) - Roche
imdatifan (NKT2152) - NiKang Therap
Tecentriq (atezolizumab) - Roche
tobemstomig (RG6139) - Roche
IO-108 - Immune-Onc Therap
amezalpat (TPST-1120) - Tempest Therap
muzastotug (ADG126) - Adagene
Avastin (bevacizumab) - Roche
Actemra IV (tocilizumab) - Roche, JW Pharma
http://clinicaltrials.gov/ct2/show/NCT04524871
 
Feb 3, 2026
 
Next